Kazia Therapeutics (KZIA) 推进癫痫试验，市场定价反映高增长预期
· gurufocus.com
2026年9月22日，Kazia Therapeutics Ltd（纳斯达克代码：KZIA）宣布其授权合作伙伴Sovargen已给药首例患者，标志着重大里程碑。
On September 22, 2026, Kazia Therapeutics Ltd (NASDAQ: KZIA) announced a significant milestone as its licensed partner Sovargen administered the first dose in a...